Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|19|7|777-781
ISSN： 1389-4501
Source： Current Drug Targets, Vol.19, Iss.7, 2018-04, pp. : 777-781
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Access to resources
Recommend
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :
Can Surgery for Inflammatory Bowel Disease be Personalized?
Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. :
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. :
Treatment of Inflammatory Bowel Disease in the Elderly: An Update
By Pardi D.S. Loftus Jr E.V. Camilleri M.
Drugs & Aging, Vol. 19, Iss. 5, 2002-05 ,pp. :